NASDAQ:RKDA
Arcadia Biosciences, Inc.
- Stock
Last Close
2.27
28/03 20:00
Market Cap
2.82M
Beta: 0.96
Volume Today
27.15K
Avg: 172.60K
PE Ratio
−0.33
PFCF: −0.20
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
cost and expenses | 17.04M - | 22.14M 29.87% | 20.98M 5.23% | 21.81M 3.96% | 18.34M 15.90% | 18.33M 0.04% | 21.55M 17.54% | 29.63M 37.48% | 35.53M 19.95% | 29.36M 17.38% | |
cost of revenue | 673K - | 2.00M 196.73% | 892K 55.33% | 895K 0.34% | 283K 68.38% | 661K 133.57% | 885K 33.89% | 5.20M 487.46% | 8.71M 67.49% | 9.80M 12.56% | |
depreciation and amortization | 391K - | 358K 8.44% | 294K 17.88% | 304K 3.40% | 279K 8.22% | 154K 44.80% | -48K 131.17% | 767K 1,697.92% | 17.16M 2,137.42% | -3.32M 119.33% | |
ebitda | -10.17M - | -14.79M 45.48% | -14.75M 0.32% | -17.98M 21.89% | -13.76M 23.48% | -22.88M 66.32% | -20.43M 10.70% | -20.82M 1.94% | -18.36M 11.81% | -22.72M 23.72% | |
eps | -322.62 - | -448.39 38.98% | -503 12.18% | -353.85 29.65% | -291.38 17.65% | -143.16 50.87% | -181.50 26.78% | -24.20 86.67% | -30.33 25.33% | -26.05 14.11% | |
eps diluted | -322.62 - | -448.39 38.98% | -503 12.18% | -353.85 29.65% | -291.38 17.65% | -143.16 50.87% | -181.50 26.78% | -24.20 86.67% | -30.33 25.33% | -26.05 14.11% | |
general and administrative expenses | 7.97M - | 10.13M 27.10% | 11.12M 9.81% | 12.25M 10.17% | 10.65M 13.05% | 11.60M 8.95% | 13.57M 16.92% | 16.47M 21.38% | |||
gross profit | 5.80M - | 4.99M 14.13% | 4.52M 9.29% | 2.29M 49.29% | 3.74M 63.24% | 803K 78.55% | 284K 64.63% | 2.83M 898.24% | -1.93M 168.01% | 154K 107.99% | |
income before tax | -11.19M - | -17.14M 53.25% | -17.93M 4.58% | -19.60M 9.31% | -15.68M 19.99% | -13.47M 14.10% | -28.87M 114.34% | -6.15M 78.70% | -16.13M 162.31% | -15.60M 3.31% | |
income tax expense | 167K - | 263K 57.49% | 26K 90.11% | 25K 3.85% | 26K 4% | 10K 61.54% | 2K 80% | -124K 6,300% | 2K 101.61% | 14K 600% | |
interest expense | 626K - | 1.39M 122.68% | 2.66M 90.67% | 1.32M 50.38% | 747K 43.37% | 5K - | 47K 840% | 20K 57.45% | 289K 1,345% | ||
interest income | |||||||||||
net income | -13.20M - | -18.34M 38.98% | -17.96M 2.09% | -19.62M 9.29% | -15.71M 19.96% | -13.48M 14.18% | -28.87M 114.19% | -6.03M 79.13% | -16.13M 167.74% | -15.61M 3.24% | |
operating expenses | 16.37M - | 20.14M 23.01% | 20.09M 0.26% | 20.91M 4.12% | 18.06M 13.65% | 17.67M 2.13% | 20.66M 16.93% | 24.43M 18.20% | 26.83M 9.83% | 19.56M 27.10% | |
operating income | -10.57M - | -15.15M 43.41% | -15.56M 2.71% | -18.62M 19.64% | -14.31M 23.12% | -16.87M 17.85% | -20.38M 20.81% | -21.59M 5.94% | -35.53M 64.53% | -19.40M 45.38% | |
other expenses | 5K - | 521K - | 340K 34.74% | 281K 17.35% | -3.61M 1,383.27% | 466K 112.92% | 105K 77.47% | 10.11M 9,532.38% | 33K 99.67% | ||
research and development expenses | 8.40M - | 10.01M 19.13% | 8.97M 10.45% | 8.66M 3.38% | 7.41M 14.50% | 6.07M 18.06% | 7.10M 16.96% | 7.96M 12.14% | 3.89M 51.14% | 1.51M 61.20% | |
revenue | 6.48M - | 6.98M 7.78% | 5.41M 22.46% | 3.19M 41.12% | 4.03M 26.29% | 1.46M 63.64% | 1.17M 20.15% | 8.03M 587.25% | 6.78M 15.61% | 9.96M 46.84% | |
selling and marketing expenses | |||||||||||
selling general and administrative expenses | 7.97M - | 10.13M 27.10% | 11.12M 9.81% | 12.25M 10.17% | 10.65M 13.05% | 11.60M 8.95% | 13.57M 16.92% | 16.47M 21.38% | 22.94M 39.30% | 18.05M 21.32% | |
total other income expenses net | 5K - | -597K 12,040% | 291K 148.74% | 340K 16.84% | -619K 282.06% | 5.96M 1,062.04% | -8.49M 242.57% | 15.44M 281.88% | 19.39M 25.59% | 3.81M 80.38% | |
weighted average shs out | 40.90K - | 40.90K 0% | 35.70K 12.72% | 55.46K 55.35% | 53.91K 2.80% | 94.16K 74.68% | 159.08K 68.94% | 248.97K 56.51% | 532.02K 113.68% | 599.39K 12.66% | |
weighted average shs out dil | 40.90K - | 40.90K 0% | 35.70K 12.72% | 55.46K 55.35% | 53.91K 2.80% | 94.16K 74.68% | 159.08K 68.94% | 248.97K 56.51% | 532.02K 113.68% | 599.39K 12.66% |
All numbers in USD (except ratios and percentages)